District Court Delivers Good News to Mylan, Barr in Amrix Litigation
Aaron F. Barkoff
•
Fri, May 13, 2011
Quote & Headlines
StockTalk
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Appeals Court Upholds Pay-to-Delay Deals, AgainPharmalot • Sun, Sep 12, 2010
-
Clolar Decision Aside, Genzyme's Still a Near-Term SellMark Mitchell • Wed, Sep 2, 2009
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008Market Folly • Thu, Jan 15, 2009
-
FDA Calendar Update: High Hopes for Amgen's Bone DrugMike Havrilla • Sun, Dec 21, 2008
-
Strong Dollar's Impact on Pharma vs. GenericsSA Editor Judy Weil • Tue, Dec 9, 2008
To learn more about Seeking Alpha Pro, click here.
-
Barr Pharmaceuticals Wins Battle to Acquire PlivaSA Editor Eli Hoffmann • Wed, Oct 11, 2006
-
Morning-After Pill = Morning After Stock Spike?David Jackson • Tue, Aug 1, 2006
-
Barr Labs On the Road to Zagreb (BRL)Rick Konrad • Wed, Jun 28, 2006
-
District Court Delivers Good News to Mylan, Barr in Amrix LitigationAaron F. Barkoff • Fri, May 13, 2011
-
Appeals Court Upholds Pay-to-Delay Deals, AgainPharmalot • Sun, Sep 12, 2010
-
Clolar Decision Aside, Genzyme's Still a Near-Term SellMark Mitchell • Wed, Sep 2, 2009
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008Market Folly • Thu, Jan 15, 2009
-
FDA Calendar Update: High Hopes for Amgen's Bone DrugMike Havrilla • Sun, Dec 21, 2008
-
Strong Dollar's Impact on Pharma vs. GenericsSA Editor Judy Weil • Tue, Dec 9, 2008
-
Barr Pharmaceuticals Inc. Q3 2008 Earnings Call TranscriptThu, Nov 6, 2008
-
Barr Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptThu, Aug 7, 2008
-
Barr Pharmaceuticals, Inc. Q1 2008 Earnings Call TranscriptWed, May 28, 2008
-
Barr Pharmaceuticals, Inc. Q1 2008 Earnings Call TranscriptFri, May 9, 2008
-
Barr Pharmaceuticals, Inc. Q4 2007 Earnings Call TranscriptTue, Mar 4, 2008
-
Barr Pharmaceuticals Q3 2007 Earnings Call TranscriptThu, Nov 8, 2007
-
Barr Pharmaceuticals Q2 2007 Earnings Call TranscriptWed, Aug 8, 2007
There are no News articles on BRL.
Company Description
We are a global specialty pharmaceutical company that operates in more than 30 countries. Our operations are based primarily in North America and Europe, with our key markets being the United States, Croatia, Germany, Poland and Russia. We are primarily engaged in the development, manufacture... More
Country: United States
